Economics ❯ Market Trends

Investment Analysis

Analyst Ratings Technology Investments Stock Performance Revenue Projections Tech Sector Analyst Reports Company Performance Revenue Growth Energy Investments Corporate Earnings Investor Behavior AI Industry Expert Predictions Analyst Opinions Tech Companies Venture Capital Stock Market Financial Performance Asset Management

FDA Panel Rejects AstraZeneca Breast Cancer Drug, Backs Prostate Therapy

The split votes highlight regulators' push for proof that early treatment changes extend lives.

Palantir Drops 20% in 2026 as Analysts See Buy Opportunity Before Earnings

NuScale Stock Drops on Fluor Exit and Analyst Cuts as Romania SMR Project Proceeds

Analysts Raise Palantir Targets After 17% Slide, Citing AIP Momentum

Tesla Doubles Austin Robotaxi Zone with Phallic-Shaped Geofence